循环时钟失调和前列腺癌:分子和临床概述
Dalia Kaakour1, Bridget Fortin2, Selma Masri2
1Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Orange, CA, USA.
Clinical Medicine Insights. Oncology
|November 30, 2023
概括
循环时钟的干扰可能在前列腺癌的发展和进展中起作用. 本综述探讨了分子,临床和流行病学联系,包括诸如黑激素和轮班工作等因素.
科学领域:
- 在瘤学瘤学.
- 时间生物学 时间生物学
背景情况:
- 循环时钟失调与各种癌症有关.
- 昼夜时钟在前列腺癌中的特定作用仍未得到充分研究.
研究的目的:
- 审查昼夜时钟失调在前列腺癌中的潜在作用.
- 检查分子,流行病学和临床数据.
- 讨论与前列腺癌有关的诸如黑激素,光线,夜班工作,慢性治疗和雄激素独立等因素.
主要方法:
- 现有研究的文献综述.
- 对分子数据的检查.
- 对流行病学和临床数据的分析.
主要成果:
- 循环时钟的干扰越来越被认为是癌症的一个因素.
- 正在确定特定的分子通路,将昼夜功能与前列腺癌联系起来.
- 流行病学数据表明,环境因素 (如轮班工作) 与前列腺癌风险之间存在潜在的关联.
结论:
- 循环时钟失调是前列腺癌的一个可能的因素.
- 需要进一步的研究来阐明精确的机制和治疗影响.
- 了解这些联系可能会为前列腺癌的新型预防和治疗策略提供信息.
更多相关视频
06:53Parallel Measurement of Circadian Clock Gene Expression and Hormone Secretion in Human Primary Cell Cultures
Published on: November 11, 2016
8.3K
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
相关概念视频
02:19Circadian Rhythms and Gene Regulation
4.1K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.1K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:20Disorders of the Male Reproductive System
424
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
424
02:39Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K